Andrew Komjathy insider trades

Open-market stock purchases and sales by Andrew Komjathy, Chief Commercial Officer at Astria Therapeutics, Inc, from SEC Form 4 filings since Sep 18, 2019.

Recent trades

DateStockTradeValue
Jan 23, 2026ATXS Astria Therapeutics, IncSold (not open market)—
Jan 23, 2026ATXS Astria Therapeutics, IncSold (not open market)—
Jan 23, 2026ATXS Astria Therapeutics, IncSold (not open market)$358K
Jan 23, 2026ATXS Astria Therapeutics, IncSold (not open market)$1.4M

Companies traded

  • ATXS Astria Therapeutics, Inc: 1 buy, last Jan 23, 2026
  • CATB Catabasis Pharmaceuticals Inc: other filings, last Jun 2, 2021

Get free alerts when Andrew Komjathy files a new trade →